Cassava Sciences stock price forecast for Q3 after shares rally 27%

Cassava Sciences stock price forecast for Q3 after shares rally 27%

Meme stock Cassava Sciences Inc. (NASDAQ:SAVA) shares surged more than 27% on Wednesday after revealing plans to present data on its Alzheimer’s drug, Simufilam, on 29th July. Cassava will read out its interim analysis on a 9-month treatment with Simulflam at the 2021 Alzheimer’s Association International Conference (AAIC) in Denver. It will cover safety and
The post Cassava Sciences stock price forecast for Q3 after shares rally 27% appeared first on Invezz.

Post a Comment